We are adapting and optimizing protocols for the differentiation of human and mouse iPSCs towards myeloid progenitors that are able to develop into microglia and border-associated macrophages in the mouse brain. These methodologies are being used as a tool to study brain macrophage biology or as a therapeutic strategy for treating brain disease.